Review and approve post-marketing Individual Case Safety Reports (lCSRs) and Serious Adverse Event (SAE) reports occurring in clinical trials for medical/causality assessment. This includes coding, assessment of seriousness, expectedness, and company causality, as well as writing of company comment, follow-up questions and analysis of similar events.